Evidence Repository
The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
Link to SEPIO compliant JSON-LD document

Variant: NM_004360.4(CDH1):c.781G>T (p.Glu261Ter)

CA121997

12234 (ClinVar)

Gene: CDH1
Condition: CDH1-related diffuse gastric and lobular breast cancer
Inheritance Mode: Autosomal dominant inheritance
Link to MONDO
UUID: ef1e305b-a891-4916-8546-9393fd0c9b4a

HGVS expressions

NM_004360.4:c.781G>T
NM_004360.4(CDH1):c.781G>T (p.Glu261Ter)
NC_000016.10:g.68810290G>T
CM000678.2:g.68810290G>T
NC_000016.9:g.68844193G>T
CM000678.1:g.68844193G>T
NC_000016.8:g.67401694G>T
NG_008021.1:g.77999G>T
ENST00000261769.10:c.781G>T
ENST00000261769.9:c.781G>T
ENST00000422392.6:c.781G>T
ENST00000561751.1:c.455-1394G>T
ENST00000562836.5:n.852G>T
ENST00000566510.5:c.625G>T
ENST00000566612.5:c.781G>T
ENST00000611625.4:c.781G>T
ENST00000612417.4:c.781G>T
ENST00000621016.4:c.781G>T
NM_004360.3:c.781G>T
NM_001317184.1:c.781G>T
NM_001317185.1:c.-835G>T
NM_001317186.1:c.-1039G>T
NM_004360.5:c.781G>T
NM_001317184.2:c.781G>T
NM_001317185.2:c.-835G>T
NM_001317186.2:c.-1039G>T
NM_004360.5(CDH1):c.781G>T (p.Glu261Ter)

Pathogenic

Met criteria codes 3
PVS1 PM5_Supporting PM2_Supporting
Not Met criteria codes 23
BS3 BS4 BS1 BS2 BP5 BP7 BP2 BP3 BP4 BP1 PS3 PS2 PS1 PS4 BA1 PP4 PP1 PP3 PP2 PM6 PM3 PM1 PM4

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen CDH1 Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 3.1

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
CDH1 VCEP
The c.781G>T (p.Glu261Ter) variant is predicted to result in a premature stop codon that leads to nonsense mediate decay (PVS1 and PM5_supporting). The variant is absent in the gnomAD cohort (PM2_supporting; http://gnomad.broadinstitute.org). Therefore, this variant meets criteria to be classified as pathogenic based on the ACMG/AMP criteria applied as specified by the CDH1 Variant Curation Expert Panel (CDH1 VCEP specifications version 3.1): PVS1, PM2_supporting, PM5_supporting.
Met criteria codes
PVS1
Predicted to introduce premature termination codon in exon 6 of 16, leading to truncation or loss of protein function.
PM5_Supporting
Predicted to introduce premature termination codon in exon 6 of 16, leading to truncation or loss of protein function.
PM2_Supporting
Absent in gnomAD cohort.
Not Met criteria codes
BS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP7
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS4
Only reported as a somatic variant in a sporadic breast cancer, not germline.
Somatic variant in a lobular breast cancer. PubMed:8557030
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM6
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Approved on: 2023-08-04
Published on: 2023-08-04
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.